Rights and permissions
About this article
Cite this article
ATLAS studies put telavancin on the map for cSSSI. Inpharma Wkly. 1587, 7–8 (2007). https://doi.org/10.2165/00128413-200715870-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715870-00012